| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/20/2000 | EP1035866A2 Mixed lipopeptide micelles for inducing an immune response and their therapeutic uses |
| 09/20/2000 | EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/20/2000 | EP1035863A1 An over-expressing homologous antigen vaccine and a method of making the same |
| 09/20/2000 | EP1035860A1 Non-toxic immune stimulating enterotoxin compositions |
| 09/20/2000 | EP1035856A1 Isolated dna encoding human h3 histamine receptor |
| 09/20/2000 | EP1035780A1 Method for purifying heat shock peptides complexes |
| 09/20/2000 | EP0934072A4 Manufacturing process for the production of purified transferrin |
| 09/20/2000 | EP0927515B1 Method of collecting insect humors |
| 09/20/2000 | EP0854883A4 Developmentally-regulated endothelial cell locus-1 |
| 09/20/2000 | EP0832119B1 Anti-fungal and anti-bacterial histatin-based peptides |
| 09/20/2000 | EP0792291B1 Protein affecting katp channels |
| 09/20/2000 | EP0766735B1 Class bi and ci scavenger receptors |
| 09/20/2000 | EP0672057B1 Analogs of pth |
| 09/20/2000 | EP0654039B1 Process for hemoglobin extraction and purification |
| 09/20/2000 | EP0623216B1 IMMUNOCHEMICAL DETECTION OF $i(IN VIVO) ADVANCED GLYCOSYLATION ENDPRODUCTS |
| 09/20/2000 | EP0600992B1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
| 09/20/2000 | EP0586549B1 Selecting ligand agonists and antagonists |
| 09/20/2000 | EP0495836B2 Dye transfer inhibition |
| 09/20/2000 | CN1267307A Interleukin-18 binding proteins, their preparation and use |
| 09/20/2000 | CN1267224A Treatment of acute lung injury and fibrosis with antagonists of 'alpha' V 'beta' b |
| 09/20/2000 | CN1267223A Carcinostatic agents |
| 09/20/2000 | CN1266902A Human membrane translocator and its coding sequence |
| 09/20/2000 | CN1266901A I-type isomer of human steroid 5 alpha reductase and its coding sequence |
| 09/20/2000 | CN1266899A Precursor heteromorphic protein of human calcium binding protein and its coding sequence |
| 09/20/2000 | CN1266898A Human carboxypeptidase precursor protein and its coding sequence |
| 09/20/2000 | CN1266714A Humanized antibody |
| 09/20/2000 | CN1056647C Production of immunoproximity catalysts |
| 09/20/2000 | CN1056619C Peptide haivng activity as inhibitors of platelet aggregation, pharmaceutical composition contg. same and use thereof |
| 09/20/2000 | CN1056618C Acylated insulin and pharmaceutical composition contg. same |
| 09/20/2000 | CN1056617C Melanoma-inhibiting protein |
| 09/20/2000 | CN1056616C Membrane protein polypeptide having supporting pre-B cell growth and gene thereof |
| 09/19/2000 | US6121521 Formed by joining the 5' portion of a synthetic maize optimized cry1b gene to the 3' end of a full-length synthetic maize optimized cry1a gene to generate a full-length hybrid cry1b gene |
| 09/19/2000 | US6121436 Nucleic acid sequence coding alfalfa fungicide protein; for prevention of parasite infection; fungicides |
| 09/19/2000 | US6121435 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 09/19/2000 | US6121427 Major outer membrane protein CD of branhamella |
| 09/19/2000 | US6121426 Fibrin binding domain polypeptides and uses and methods of producing same |
| 09/19/2000 | US6121421 Simple, efficient two step extraction process; mixing crude preparation with buffer in which beta-casein is insoluble, pelleting beta-casein by centrifuging, suspending pellet in buffer and solubilizer, centrifuging, supernatant has casein |
| 09/19/2000 | US6121420 Chitin binding protein; for the accurate detection of fungal infections and treatment of aquired immune deficiency syndrome; viricides |
| 09/19/2000 | US6121419 Protein for the diagnosis and monitoring of types of leukemia in humans |
| 09/19/2000 | US6121418 PNA synthesis using a base-labile amino protecting group |
| 09/19/2000 | US6121417 Inhibitors of retroviral protease |
| 09/19/2000 | US6121416 Peptide which prevents the binding of somatomedins and their binding proteins; for the treatment of hyperglycemic, obesity, nervous system, cardiovascular, kidney, immunological and metabolic disorders |
| 09/19/2000 | US6121415 An epidermal growth factor receptor polypeptide; for the treatment of nervous system disorders and nervous system damage |
| 09/19/2000 | US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides |
| 09/19/2000 | US6121247 Locally administering to patient preparation comprising dna expression construct comprising human gamma-interferon coding sequence |
| 09/19/2000 | US6121238 Peptides and compounds that bind to a receptor |
| 09/19/2000 | US6121237 Administering peptide derived from primary amino acid sequence of human tumor necrosis factor to treat depressed neutrophil, macrophage or monocyte function |
| 09/19/2000 | US6121236 Multivalent ligands which modulate angiogenesis |
| 09/19/2000 | US6121233 Methods for the inhibition of cancer metastasis mediated by endothelial adhesion molecules |
| 09/19/2000 | US6121232 Stabilized mixture comprising fibrinogen |
| 09/19/2000 | US6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury |
| 09/19/2000 | US6121045 Nucleotide and amino acid sequences; involved in modulating the growth and/or differentiation of endothelial cells; treatment and diagnosis of nervous system and vascular system disorders; alzheimer's/parkinson's diseases |
| 09/19/2000 | US6121044 Potent antigen presenting cell composition |
| 09/19/2000 | US6121037 Nucleic acid which encodes protein having defined amino acid sequence; for diagnostic reagents against neisseria species infections such as gonorrhea and meningitis; vaccines |
| 09/19/2000 | US6121035 Amino acid sequences; for screening drugs and producing antibodies |
| 09/19/2000 | US6121029 Nucleotide sequences encoding at least one polypeptide from polyketide synthase; for recombinant production of anticarcinogenic agents |
| 09/19/2000 | US6121021 Modified human immunodeficiency virus genome devoid of long terminal repeats, with vpr and tat sequences disabled, and linked to constitutive promoter; for stable, long-term production of nonreplicating immunogens for vaccines |
| 09/19/2000 | US6121020 Secreted complex of polypeptides lacking all or portion of transmembrane domain; for vaccines produced by recombinant production |
| 09/19/2000 | US6121019 Polynucleotide fragment encoding human polypeptide of defined amino acid sequence; diagnosis, prevention, and treatment of inflammation, disorders associated with cell proliferation and apoptosis; antiinflammatory/antiproliferative agents |
| 09/19/2000 | US6121017 Nucleotide and amino acid sequences; for diagnostic evaluation and prognosis of various disorders |
| 09/19/2000 | US6121016 DNA encoding human follicle stimulating hormone receptor, vectors and cells containing such DNA, and methods of use thereof |
| 09/19/2000 | US6121015 Drug screening by transfecting cells with nucleic acid, expressing receptor, selecting compounds binding to receptor, comparing binding to other receptors, choosing compounds which have lower affinity to other receptors |
| 09/19/2000 | US6121014 Method for producing a plant-optimized nucleic acid coding sequence |
| 09/19/2000 | US6121005 Human growth arrest specific homeobox protein; transcription factor; for treatment of postangioplasty restenosis and other cardiovascular disorders; for screening cellular partners |
| 09/19/2000 | US6121004 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| 09/19/2000 | US6121003 Monoclonal antibodies specific for an epitope of phosphorylated tau, and their use |
| 09/19/2000 | US6120995 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 09/19/2000 | US6120989 Isolated human cytomegalovirus polypeptides and uses thereof |
| 09/19/2000 | US6120988 Method of detecting hev infection |
| 09/19/2000 | US6120776 Kit containing vaccine and diagnostic test |
| 09/19/2000 | US6120773 Recombinant herpes simplex viruses vaccines and methods |
| 09/19/2000 | US6120770 Isolated polypeptide |
| 09/19/2000 | US6120769 Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
| 09/19/2000 | US6120767 Genetic engineering |
| 09/19/2000 | US6120765 Purified peptide |
| 09/19/2000 | US6120763 Compositions and methods for enhanced tumor cell immunity in vivo |
| 09/19/2000 | US6120762 Genetic engineering |
| 09/19/2000 | US6120761 Mixture containing histidine stabilizer |
| 09/19/2000 | US6120760 Isolated protein; hybrid; bone disorders |
| 09/19/2000 | US6120491 Selective removal of benzyl esters to form pendent carboxylic acid groups by palladium-catalyzed hydrogenolysis from poly-arylates and polycarbonates in a tertiary-amide solvent; kinetics; surgical barriers; implant coatings; drug delivery |
| 09/19/2000 | CA2300475A1 Cre-inducible expression system |
| 09/19/2000 | CA2266295A1 Method of modifying plant metabolism and development |
| 09/19/2000 | CA2223236C Method for purifying thrombopoietin |
| 09/19/2000 | CA2071538C Hpth (1-37) fragment, its production, drug containing it and its use |
| 09/19/2000 | CA2065365C Bovine coronavirus polypeptides and vaccines |
| 09/19/2000 | CA2053242C Protease inhibitor |
| 09/19/2000 | CA2050601C Production in bacteria and yeast of hemoglobin and analogues thereof |
| 09/17/2000 | CA2300782A1 Modified factor viii cdna |
| 09/14/2000 | WO2000053808A1 Beclin and uses thereof |
| 09/14/2000 | WO2000053793A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 09/14/2000 | WO2000053790A1 Target cell-specific, multivalent proteins (mvp) |
| 09/14/2000 | WO2000053787A1 Prrsv vaccines |
| 09/14/2000 | WO2000053785A2 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins |
| 09/14/2000 | WO2000053784A1 Methods of using viral replicase |
| 09/14/2000 | WO2000053782A2 Herbicide target genes and methods |
| 09/14/2000 | WO2000053779A1 Translation regulation system and methods for use thereof |
| 09/14/2000 | WO2000053777A1 Preparation of peptides by use of human glucagon sequence as a fusion expression partner |
| 09/14/2000 | WO2000053776A2 Human kallikrein-like genes |
| 09/14/2000 | WO2000053767A2 Nucleic acid respiratory syncytial virus vaccines |
| 09/14/2000 | WO2000053766A1 Non-spreading pestivirus |